Status:
COMPLETED
Interest in the Use of Nasal High-Flow Oxygen Therapy (OptiFlow™) in Secondary Transport of COVID-19 Positive Patients
Lead Sponsor:
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
Since the beginning of COVID-19 pandemic situation, several modes of ventilation have been tried to correct the hypoxaemia induced by SARS-CoV-2 virus. A few recent studies have concluded that high-fl...
Detailed Description
Retrospective observational study in France including COVID-19 infected patients taken care of by the emergency medical service 83 (SAMU 83) for a secondary transport between1st March 2020 and 31th De...
Eligibility Criteria
Inclusion
- COVID-positive patient diagnosed either by positive Polymerase Chain Reaction (PCR) or radiological interpretation of chest CT
- Patient in respiratory distress treated during transport by high flow nasal oxygen or HCM (with a minimum flow of 15 L/min) or other NIV modes
- Patient taken care of by the emergency medical service 83 (SAMU 83) for secondary transport (transfer from an intensive care unit/other hospital unit/emergency department to another hospital's intensive care unit) between1st March 2020 and 31th December 2021
Exclusion
- Pre-transport intubation
- Patient opposition to participate in the study
Key Trial Info
Start Date :
March 24 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 25 2022
Estimated Enrollment :
229 Patients enrolled
Trial Details
Trial ID
NCT05289141
Start Date
March 24 2022
End Date
April 25 2022
Last Update
October 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hopitalier Intercommunal Toulon - La Seyne sur Mer
Toulon, Var, France, 83056